Medicare Enrolled

Dr. Evelyn Musni, M.D.

Nuclear Cardiology Physician · Fremont, CA
Practice pattern: Cardiac Imaging — Practice with significant diagnostic imaging and stress testing
Low-engagement
1860 MOWRY AVE STE 200, Fremont, CA 94538
5107902202
In practice since 2005 (20 years)
NPI: 1699751222 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Musni from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Musni? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Musni

Dr. Evelyn Musni is a nuclear cardiology physician in Fremont, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Musni performed 9,338 Medicare services across 4,174 unique beneficiaries.

Between the years covered by Open Payments, Dr. Musni received a total of $131 from 5 pharmaceutical and/or device companies across 7 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nuclear cardiology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Musni is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 16% volume in CA $131 industry payments

Medicare Practice Summary

Medicare Utilization ↗
9,338
Medicare services
Top 16% in CA for nuclear cardiology physician
4,174
Unique beneficiaries
$188
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~467 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Intravenous injection of additional new drug or substance
Administration of an additional new medication or substance directly into a vein.
2,857 $16 $50
Regadenoson injection (Lexiscan) for heart stress test
An injection of regadenoson, a medication used to stress the heart during diagnostic testing.
1,521 $45 $95
Technetium Tc-99m tetrofosmin diagnostic injection
A diagnostic injection of Technetium Tc-99m tetrofosmin used for imaging studies.
796 $75 $175
Adenosine injection, 1 mg
Administration of a 1 mg dose of adenosine medication. This code is specifically for adenosine and excludes adenosine phosphate compounds.
683 $0 $10
Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries 656 $408 $1,250
Intravenous drug injection
A procedure involving the administration of a medication or substance directly into a vein.
535 $39 $100
Nuclear stress test of heart muscle
A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera.
398 $462 $1,018
Exercise or drug-induced heart stress test with ECG
A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review.
386 $64 $200
Aminophylline injection, up to 250 mg
Administration of aminophylline medication via injection for a dose of up to 250 mg.
385 $7 $15
Nuclear stress test with CT scan
A nuclear medicine imaging test that evaluates blood flow in the heart muscle at rest and during stress, performed alongside a concurrent CT scan.
331 $1,910 $3,002
PET scan of heart muscle blood flow
A nuclear medicine imaging test that uses positron emission tomography (PET) to evaluate blood flow within the heart muscle.
324 $136 $300
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries 117 $281 $800
SPECT nuclear medicine scan, 1 area
A nuclear medicine imaging test using a single photon emission computed tomography (SPECT) scan to create detailed images of one specific area of the body.
109 $377 $640
Nuclear medicine heart muscle metabolic study
A nuclear medicine test that evaluates the metabolic activity of the heart muscle. This procedure uses radioactive tracers to assess how well the heart tissue is functioning.
84 $1,003 $2,500
I-123 ioflupane diagnostic injection
A diagnostic injection of I-123 ioflupane used for imaging studies, with a dose up to 5 millicuries.
84 $2,206 $4,071
Brain nuclear medicine study with metabolic evaluation
A nuclear medicine imaging test that uses radioactive tracers to evaluate brain metabolism. This procedure helps assess how brain tissues are functioning at a metabolic level.
26 $1,645 $2,500
Bone density scan (DEXA)
A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures.
20 $49 $270
Nuclear medicine scan from skull base to mid-thigh with CT
A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan.
13 $1,696 $2,500
Technetium Tc-99m medronate diagnostic injection
An injection of Technetium Tc-99m medronate used for diagnostic imaging studies. The dose administered is up to 30 millicuries per study.
13 $12 $150
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$131
Total received (2018-2024)
Avg $26/year across 5 years
Bottom 11% in CA for nuclear cardiology physician
5
Companies
7
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$131 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$18
2023
$26
2022
$53
2021
$17
2018
$17

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$18
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Progenics Pharmaceuticals, Inc.
$50
Life Molecular Imaging Ltd
$30
Lilly USA, LLC
$18
iRhythm Technologies, Inc.
$17
Biogen, Inc.
$17
Top 3 companies account for 73.8% of all-time payments
Associated products mentioned in payments ›
ADUHELM · AMYVID · NEURACEQ · PYLARIFY · ZIO Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a nuclear cardiology physician in Fremont?
Compare nuclear cardiology physicians in the Fremont area by procedure volume, costs, and industry payment transparency.
Browse nuclear cardiology physicians nearby

Geographic Context

Nuclear cardiology physicians within 10 mi
7
Per 100K population
0.4
County median income
$126,240
Nearest hospital
WASHINGTON HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Musni is a cardiac imaging specialist, with above-average Medicare volume (top 16% in CA), with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Musni experienced with intravenous injection of additional new drug or substance?
Based on Medicare claims data, Dr. Musni performed 2,857 intravenous injection of additional new drug or substance services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Musni receive payments from pharmaceutical companies?
Yes. Dr. Musni received a total of $131 from 5 companies across 7 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Musni's costs compare to other nuclear cardiology physicians in Fremont?
Dr. Musni's average Medicare payment per service is $188. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Musni) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →